New Delhi Metallo beta-lactamase (NDM) is of significant public health concern due to its enormous potential to hydrolyse all major beta-lactams including carbapenems. Amino acid substitutions outside the active site reportedly affect NDM beta-lactamase activities. Here, the effect of amino acid substitutions in the possible omega-like loop region of NDM-5 has been elucidated. Overall, three substitution mutations near active site of NDM-5 were done, namely, E152A, S191A and D223A and subsequently, the change in antimicrobial resistance was monitored upon expressing each mutant in a suitable host. Among the three mutants, E152A substitution on a loop near the active site resulted in significant reduction in beta-lactam antibiotic resistance as compared to NDM-5 that compelled us to conduct further studies on the E152A-substituted NDM-5. The purified NDM-5 was able to hydrolyse all the beta-lactams tested whereas the E152A mutation suppressed its activities. NDM-5 showed maximum k cat /K m ratio against penicillins and carbapenems and had lower K m as compared to NDM-5 E152A. Though, the amino acid substitution did not affect the overall folding pattern of NDM-5, significant differences in thermal stability between the wild-type and mutated protein were observed. Therefore, we infer that the E152 residue is important in regulating the beta-lactam hydrolysing properties of NDM-5.
INTRODUCTION
Metallo beta-lactamases (MBLs) (EC: 3.5.2.6) are a class of zinc (Zn)-containing enzymes, produced within both Gramnegative and Gram-positive bacteria (Livermore 1995) , hydrolysing the amide bond of the beta-lactam ring of penicillins, cephalosporins and carbapenems group of antibiotics resulting in loss of their antibacterial properties. Presently, there are 29 known MBLs and these enzymes have been classified into three subclasses (B1, B2 and B3) based on primary amino acid sequence and function (Palzkill 2013) . The most clinically important MBLs belong to subclass B1 that includes VIM (Verona integrin-encoded MBLs), IMP (imipenamase) and NDM (New Delhi MBLs), each having multiple variants (Makena et al. 2014) .
Ever since the discovery in 2008, prevalence of NDM variants has been reported worldwide among both Gram-negative and -positive bacteria (Kumarasamy et al. 2010; Nordmann et al. 2011) . Unfortunately, the coexistence of bla OXA and bla SFO with bla NDM has led to evolution of multidrug-resistance strains (Karthikeyan, Thirunarayan and Krishnan 2010; Zhao et al. 2015) . Increased conjugation efficiency of bla NDM -carrying plasmids among Enterobacteriaceae species including Klebsiella pneumoniae with enhanced ability to produce biofilms at room temperature propels the dissemination of multidrug-resistance mechanism including carbapenamse activity (Potron, Poirel and Nordmann 2011; Chung 2016 ) in tropical and sub-tropical regions of the world. Unlike serine beta-lactamases, NDM is not inhibited by the classical irreversible beta-lactamase inhibitors (clavulanic acid, sulbactam, tazobactam and avibactam), but instead NDMs are inhibited by metal chelators such as ethylenediaminetetraacetic acid (EDTA) and o-phenanthroline with proven potential toxicity in clinical trials (Bebrone 2007; Tamilselvi and Mugesh 2008; Bush and Jacoby 2010; Drawz, Papp-Wallace and Bonomo 2014) . The predominance of metallo-proteins in the human body sets another limitation for chelator-based inhibitors if they bind non-specifically as they can lead to lethal complications (Franz 2013) .
Amino acids substitution in MBLs lead to changes in activity and in some cases can confer selective advantage during evolution of drug resistance (Makena et al. 2014) . Presence of glutamate, aspartate and serine residues near the omega-loop of serine beta-lactamases has been proven to confer hydrolytic reactions by sequestering water molecules at the active site for the final deacylation reactions (Delaire et al. 1991; Vakulenko et al. 1995) .
Bioinformatics analyses show that glutamate residues are conserved in the possible omega-like loop regions among NDM variants at position 152, which is present at the junction of an alpha-helix and a loop near active site. Interestingly, the presence of glutamate at position 146 in VIM-1 and aspartate at position 127 in IMP-1 near the zinc active site (Fig. 1 ) predicts the evolutionary resemblance among MBLs. To understand the importance of such residues in catalytic reactions, in this work, we created three substitution mutations near the zinc-binding active site at position glutamate152 (E152), serine191 (S191) and aspartate223 (D223) of NDM-5 with alanine and checked their resistance profile to understand the significance of such mutations. Here, alanine is used because it does not eliminate the side chain beyond the β carbon without altering the main-chain conformation nor it does impose extreme electrostatic or steric effects (Cunningham and Wells 1989) . Furthermore, we analysed alterations in the specificity of a selected E152A mutant with the parent protein to evaluate the impact of the mutation on antibiotic susceptibility, enzyme activity and thermal stability.
MATERIALS AND METHODS

Bacterial strains and plasmids
Plasmid DNA harbouring bla NDM-5 isolated from Klebsiella pneumoniae clinical isolates, and all the genetic manipulations and experiments were done in Escherichia coli. Plasmids pBAD18-Cam (arabinose inducible) and pET28a (lactose/IPTG inducible) were used. Escherichia coli strain BL21 (DE3) pLysS was used for protein expression and purification. Laboratory strain E. coli CS109 (K-12) was used for cellular evaluation of MBL activity. Three-dimensional superimposed model of MBL proteins of K. pneumoniae, generated with PyMOL (www.pymol.com) using PHYRE2 protein fold recognition server to generate the PDB files. The enzyme-active sites and target residues under investigation are shown as sticks. Protein structure and residues of NDM-5 have been shown in green colour, IMP-1 in magenta and VIM-1 in blue colours, respectively.
Antibiotics and reagents
All the culture media used were purchased from Hi-media (Mumbai, India). Antibiotics and reagents were procured from Sigma-Aldrich, (St. Louis, MO, USA) and the molecular biology reagents from New England Biolabs (Ipswich, MA, USA).
Recombinant DNA methodology and mutagenesis
The bla NDM-5 gene was amplified with specific primers designed for both full-length and soluble protein (devoid of signal peptide and a portion of C-terminal amphipathic marker) constructs in pBAD18-Cam (pBN5) and pET28a (+) (pETN5), respectively (Table S1 , Supporting Information). Obtained clones were confirmed by sequencing through commercial sequencing services (MWG Biotech, Bangalore, India). A total of three substitution mutations were carried out using Quick Change II XL Site-Directed Mutagenesis Kit (Agilent Technologies, CA, USA) by following the manufacturer's protocol and the mutations are E152A, S191A and D223A.
Antibiotic susceptibility test
Antibiotic susceptibilities were quantified using disc diffusion tests (Table S2a , Supporting Information) and determining minimum inhibitory concentrations (MIC), as previously discussed (Sarkar et al. 2011) , and the results were interpreted according to Clinical and Laboratory Standard Institute (CLSI) guidelines (Jorgensen and Turnidge 2015) . Disc diffusion assays were done using carbapenem disc (10 μg) dispensed on MH (Muller-Hinton, cation adjusted) agar plates, inoculated with 0.5 McFarland E. coli CS109 strains harbouring full-length genes.
Cellular MBL production was assessed by the EDTAimipenem(IPM)/ EDTA-nitrocefin synergy test. Disc diffusion assay was done in the presence of an IPM (10 μg) disc soaked with EDTA (10 μl of 0.5 M) and without EDTA. Nitrocefin assay was done with NDM-5 expressed CS109 cell lysates in Tris-Cl buffer, pH 7.4, in the presence of 100 μM nitrocefin as substrate (Dutta et al. 2015) and 0.5 mM EDTA as inhibitor. Furthermore, the rate of reaction of both NDM-5 and its mutant protein in expressed cell lysates was assessed for 30 min to confirm the nature of activity of both expressed proteins in vivo.
Purification and biophysical analysis
The expressed proteins from pETN5 with an N-terminal 6× histidine tag were purified by Ni-NTA-based metal affinity chromatography using AKTA prime plus (GE healthcare, Piscataway, New Jersey, USA) as described earlier with some modifications. The expression level and activity of protein were confirmed for both soluble and full-length construct via nitrocefin hydrolysis. The purity of the active proteins was not analysed through western blot because the method also identifies inactive proteins.
The molecular mass of purified proteins was determined via Matrix-Assisted Laser Desorption/Ionisation-Time of Flight (MALDI-ToF) spectra using VOYAGER-DE PRO, Applied Biosystem, USA. The mass spectra were acquired in the mass range of m/z 10 000 to 40 000 Da. The protein secondary structure analysis and thermal stability were measured using circular dichroism (CD) spectral analysis with JASCO J-815 CD spectrometer (JASCO international company limited, Tokyo, Japan) at 190-240 nm wavelengths, temperature 10
• C-90 • C; data were recorded at every 10
• C interval at ramp rate of 1 et al. 2015 ) in a 0.1 cm pathlength cuvette with 1 mg mL −1 protein concentration in 10 mM Tris-Cl buffer having 150 mM NaCl (pH 7.4). Data were recorded at 0.2 nm step resolution; time constant 1 s, sensitivity 10 milli degrees, with scan speed of 50 nm min
and a spectral bandwidth of 2 nm. To reduce the noise and random instrumental error, an average spectrum of four successive accumulations were taken over 190-240 nm range.
Assessment of enzyme activities
Kinetic parameters of the purified proteins with beta-lactam substrates were determined by monitoring the hydrolysis spectrophtometrically at 25
• C in 10 mM Tris-Cl buffer (pH 7.5) supplemented with 1 μg mL −1 BSA, 10 μM ZnSO 4 for stability and enhanced activity. Kinetic constants like, enzyme affinity (K m ), turnover number (k cat ) and enzyme efficiency (k cat /K m ) values were obtained by determining the initial rate of the reaction at different substrate concentrations by following the method described earlier . The concentration dependence of the initial rate was fitted and analysed using online curve-fitting tool (https://www.mycurvefit.com, MyAssays Ltd., Brighton, UK).
RESULTS AND DISCUSSIONS
EDTA inhibition confirmed MBL activity
Both the EDTA-IPM/EDTA-nitrocefin synergy assay confirmed positive for MBL activity of the NDM-5 clone; a differential of 10 mm in the zone of inhibition (ZOI) between the non-EDTA and EDTA-containing IPM disc, and inhibition of hydrolysis of nitrocefin in the presence of EDTA-confirmed cellular MBL activity. The rate of reaction of both E152A mutant and native proteins with nitrocefin was equally substantial, though the rate of reaction of mutant was slower at lower substrate concentration initially but attained equivalent rate of parent protein at higher substrate concentration confirming no anomaly in protein-active site structure after the point mutation (Fig. S1 , Supporting Information).
Mutation compromised the antibiotic resistance of NDM-5
Overall, three substitution mutations were targeted at different flexible loop regions of NDM-5 near the active site to determine the individual role of mutated residues on antimicrobial resistance (Table 1; Table S2a , Supporting Information). Substitution mutation at S191 and D223 did not have any effect in resistance alteration of NDM-5 and behaved as parent during MIC assay and disc diffusion assay. Furthermore, mutations at S191 and D223 had approximately same impact as of E152 position against doripenem, and meropenem as observed by disc diffusion test. Nevertheless, the impact was much more robust against IPM for E152A substitution. E152A mutation resulted in 5-fold increased ZOI against IPM than normal bla NDM-5 -harbouring Escherichia coli CS109 cells. Besides, E152A substitution exerted >2.5-fold increased ZOI against IPM compared to S191A and D223A substitutions, respectively. As E152A substitution of NDM-5 had the most significant impact on resistance profile against the beta-lactam antibiotics tested, unless otherwise specified, further analytical studies, including in vivo antibiotic sensitivity testing, purification and kinetic assessments, were conducted on the E152A substituted NDM-5. a EDTA used at fixed sub-inhibitory concentration of 0.4 mM.
The host E. coli strain CS109 harbouring bla NDM-5 displayed a resistant status with >60-fold increased MIC than CS109 itself for all penicillins, cephalosporin and carbapenems considered for study (Table 1) . However, the presence of sub-inhibitory concentration of EDTA reduced the MIC to sensitive level indicating that the enhancement in resistance was due to the in trans expression of bla . Similar effect was also observed for the disc-diffusion assay with the carbapenems, especially for IPM (Table S2b , Supporting Information). Interestingly, mutated NDM-5 E152A showed >60-fold reduced MIC for penicillins and carbapenems, which was equivalent to CS109 without bla . Furthermore, the MIC of the host-harbouring NDM-5 E152A was reduced by >30-fold and >15-fold for cephalothin and cefoperazone, respectively. Sub-inhibitory concentration of EDTA further reduced the MIC of CS109/ NDM-5 E152A by 4-fold for amoxicillin and by 8-fold for IPM whereas susceptibility pattern remained unperturbed for cephalosporin suggesting no residual MBL activity. Moreover, the susceptibilities of CS109/ NDM-5 S191A and CS109/ NDM-5 D223A remain unchanged for IPM and meropenem than that of the wild-type NDM-5, though upon addition of EDTA the resistance of the strains containing NDM-5 S191A and NDM-5 D223A were reduced by ∼25 fold, indicating that MBL activity of NDM-5 was the reason for such elevated resistance against carbapenems tested (Table 1) . However, the results also emphasise the fact that both S191A and D223A mutations in NDM5 did not affect its MBL nature as the susceptibility profile against carbapenems remained same upon expressing the mutated proteins.
Therefore, in summary, the substitution at position 152 in NDM-5 has made the enzyme-harbouring cells susceptible to penicillin, cephalosporin and carbapenem antibiotics confirming a significant role of E152 in exerting resistance.
NDM-5 mutant displayed reduced thermal stability
To check whether the pattern of the cellular result was reproducible in vitro, the active forms of NDM-5 and its mutant were purified to homogeneity. Mass spectroscopy analysis showed the molecular mass close to the theoretical value for both NDM-5 and its mutant (Fig. 2) . Also, CD spectra of both proteins were superimposable and showed characteristics of αββα fold conserved among MBLs (Carfi et al. 1995) . The emergence of spectra minima between 205 and 225 nm confirmed the dominance of beta-sheets followed by alpha helix, turns and random coils (Fig. 3A) . Interestingly, thermal unfolding experiments emphasised the importance of the mutated residue (E152) in maintenance of beta-sheet conformations which are crucial for NDM activity. NDM-5 showed a high unfolding temperature (>60
• C), whereas its mutated counterpart had lower unfolding temperature between 50
• C and 60
• C (Fig. 3B-D) . Moreover, NDM-5 E152A had lower beta-sheet percentage beyond 60
• C while the NDM-5 maintained the substantial beta-sheet percentage in the same temperature range (Fig. S2 , Supporting Information). Subsequently, the alpha helices, turns and random coils were increased exponentially for both proteins with increase in temperature. Therefore, the above results clearly indicate that the E152A mutation has affected the thermal stability of the NDM-5, especially by reducing the beta-sheet structure.
E152A mutation reduced catalytic activity of NDM-5
To understand whether the kinetic behaviours of NDM-5 and NDM-5 E152A were in synchrony with MIC data, K m , k cat and k cat /K m values for various beta-lactam substrates were determined (Table 2) . NDM-5 hydrolysed all beta-lactam substrates tested and showed low K m and high k cat values for the substrates. Nevertheless, NDM-5 E152A displayed considerable change in kinetic parameters with increased K m and decreased k cat and eventually, decreased k cat /K m ratio as compared to NDM-5. The penicillins and carbapenems were readily hydrolysed by NDM-5 with high K cat /K m values than cephalosporin (cephalothin) bearing neutral R groups. Although the turnover numbers for penicillins were the highest, the K m values demonstrate that carbapenems are better substrates for both mutated and native proteins. However, NDM5 E152A showed 7-14 times lower enzyme efficiency than NDM-5 towards meropenem and ampicillin. Moreover, substantial variations were also recorded in K m and k cat values for the NDM5 E152A and NDM-5. In summary, based on the obtained results here we infer that E152A mutation at the probable omega-loop of NDM-5 plays a crucial role in conferring beta-lactam hydrolysis and subsequent resistance, especially for the carbapenems. However, further investigations are needed to generalise the role of 
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